drugset / Trial / NCT02293018

Pharmacokinetic Study of MTC896 Gel in Subjects With Acne

NCT02293018 ↗

Phase 1/2 Completed 32 enrolled Mimetica Pty Limited
RandomizedParallel-groupSingle-blind

Summary

The purpose of this study is to determine the pharmacokinetic properties of topically applied MTC896 Gel following application of 0.75% (w/w) MTC896 Gel once daily and twice daily and 1.5% (w/w) once daily over 4 weeks in the treatment of acne.

Timeline

Start
2014-08
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject MTC896 Unknown 0.75 % Topical
Subject MTC896 Unknown 1.5 % Topical

Indications